A Patient-Derived Glioblastoma Organoid Model for Testing Personized Treatment Strategies

Time: 9:20 am
day: Day Two


  • A simple patient-derived glioblastoma organoid model and biobank that recapitulates inter- and intra-tumoral heterogeneity
  • Testing personized drug treatment of strategy based on mutation and gene expression characteristics of the tumor
  • Application of the glioblastoma organoid model for CAR-T treatment testing